It Seems Icu Medical Inc (NASDAQ:ICUI) Will Go Down. Just Reported More Shorted Shares

ICU Medical, Inc. (NASDAQ:ICUI) Logo

Investors sentiment increased to 1.1 in Q2 2019. Its up 0.04, from 1.06 in 2019Q1. It increased, as 24 investors sold ICU Medical, Inc. shares while 73 reduced holdings. 30 funds opened positions while 77 raised stakes. 18.75 million shares or 2.49% more from 18.29 million shares in 2019Q1 were reported.
81 were accumulated by Csat Investment Advisory Limited Partnership. Bancshares Of America De, a North Carolina-based fund reported 70,263 shares. Hollencrest Capital Mngmt invested in 1,125 shares or 0.04% of the stock. Pura Vida Investments Limited Liability Co accumulated 79,119 shares. Millennium Mgmt Ltd Limited Liability Company reported 0% in ICU Medical, Inc. (NASDAQ:ICUI). Chicago Equity Ltd Liability accumulated 3,503 shares. Oregon Pub Employees Retirement Fund stated it has 6,741 shares or 0.02% of all its holdings. Utd Automobile Association owns 3,261 shares for 0% of their portfolio. Los Angeles Capital Management & Equity stated it has 7,481 shares or 0.01% of all its holdings. 14,720 are owned by Bnp Paribas Arbitrage Sa. Moreover, Gamco Et Al has 0.07% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 37,965 shares. Barton Investment holds 0.12% or 3,120 shares. Parametric Portfolio Associate Ltd Liability Com invested in 29,502 shares. Sei invested in 4,741 shares or 0% of the stock. Hightower Advsrs Lc owns 0% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 1,825 shares.

The stock of Icu Medical Inc (NASDAQ:ICUI) registered an increase of 12.57% in short interest. ICUI’s total short interest was 843,600 shares in September as published by FINRA. Its up 12.57% from 749,400 shares, reported previously. With 191,900 shares average volume, it will take short sellers 4 days to cover their ICUI’s short positions. The short interest to Icu Medical Inc’s float is 4.44%.

The stock increased 1.68% or $2.7 during the last trading session, reaching $162.65. About 165,099 shares traded. ICU Medical, Inc. (NASDAQ:ICUI) has declined 10.38% since September 13, 2018 and is downtrending. It has underperformed by 10.38% the S&P500.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $3.36 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patientÂ’s vein for use in hospitals and ambulatory clinics. It has a 75.37 P/E ratio. The companyÂ’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

More notable recent ICU Medical, Inc. (NASDAQ:ICUI) news were published by: Seekingalpha.com which released: “ICU Medical EPS beats by $0.23, misses on revenue – Seeking Alpha” on August 07, 2019, also Benzinga.com with their article: “What Caused The Opening Gap In ICU Medical? – Benzinga” published on August 08, 2019, Finance.Yahoo.com published: “ICU Medical, Inc. (NASDAQ:ICUI) Earns A Nice Return On Capital Employed – Yahoo Finance” on August 03, 2019. More interesting news about ICU Medical, Inc. (NASDAQ:ICUI) were released by: Globenewswire.com and their article: “ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call – GlobeNewswire” published on April 18, 2019 as well as Nasdaq.com‘s news article titled: “ICU Medical (ICUI) Misses Q2 Earnings Estimates – Nasdaq” with publication date: August 07, 2019.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.